Protecting uninterrupted access to cancer care remains a top advocacy priority for ACCC. Safeguarding the ability of multidisciplinary cancer care teams to continue to focus their time on caring for, and treating, patients with cancer is another prime concern.
In comments submitted to CMS, ACCC highlights concerns that the Medicaid community engagement requirements in the final interim rule could make it much harder for some patients with cancer to maintain coverage and access needed treatment. Read the full letter.
January 21, 2026
October 30, 2025
Understanding both the benefits to be had from offering BsAb therapy to its community and the scope of this undertaking, Vanderbilt-Ingram Cancer Center took a novel approach with its APP-led BsAb step-up dosing clinic, which won the program a 2026 ACCC Innovator Award.
